Search -

Displaying 1 - 20 of 33

Sort: Relevancy | Date

News Daily News

European Experts Provide Advice on Managing CV Effects of COVID-19

Todd Neale

September 19, 2025

News Daily News

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

Yael L. Maxwell

February 25, 2025

News Daily News

Heart Failure and Cancer: HFSA Statement Explores the Interplay

Caitlin E. Cox

October 24, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

Statins Might Help in HFpEF—Even in the Absence of ASCVD

Todd Neale

May 01, 2024

News Daily News

Top Heart Failure News of 2023

Shelley Wood

January 05, 2024

News Daily News

HF Specialists Detail ‘Road Map’ for Improving HF Training Pipeline

Shelley Wood

January 04, 2023

News Daily News

Study Affirms Higher CVD, Mortality Risks Among COVID-Positive Patients

Todd Neale

October 26, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Daily News

Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19

Michael O'Riordan

July 20, 2022

News Daily News

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

Michael O'Riordan

January 20, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

In Adults, CV Pathology Dominates COVID-19 Multisystem Inflammatory Syndrome

Shelley Wood

September 23, 2021

News Daily News

Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns

Shelley Wood

July 20, 2021

More Evidence Links Myocarditis to mRNA COVID-19 Vaccines

News Daily News

CDC Says Myocarditis ‘Likely’ Linked to mRNA Vaccines but Very Rare

Shelley Wood

June 24, 2021

News Daily News

Pneumonia in HF Patients Is Common, Lethal, and Preventable

L.A. McKeown

April 19, 2021

News Daily News

Echo Aids Diagnosis, Risk Prediction in Severe COVID-19

Shelley Wood

October 26, 2020

News Daily News

‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study

Michael O'Riordan

August 26, 2020

Advertisement

European Experts Provide Advice on Managing CV Effects of COVID-19

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

Heart Failure and Cancer: HFSA Statement Explores the Interplay

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Statins Might Help in HFpEF—Even in the Absence of ASCVD

Top Heart Failure News of 2023

HF Specialists Detail ‘Road Map’ for Improving HF Training Pipeline

Study Affirms Higher CVD, Mortality Risks Among COVID-Positive Patients

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

In Adults, CV Pathology Dominates COVID-19 Multisystem Inflammatory Syndrome

Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns

More Evidence Links Myocarditis to mRNA COVID-19 Vaccines

CDC Says Myocarditis ‘Likely’ Linked to mRNA Vaccines but Very Rare

Pneumonia in HF Patients Is Common, Lethal, and Preventable

Echo Aids Diagnosis, Risk Prediction in Severe COVID-19

‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content